Clinical Trial: Role of Placenta Growth Factor in Sickle Acute Chest Syndrome

Study Status: Completed
Recruit Status: Completed
Study Type: Observational




Official Title: Role of Placenta Growth Factor in Sickle Acute Chest Syndrome

Brief Summary: The purpose of this research study is to find out whether Placenta Growth Factor (PlGF) and related tests can predict the development of acute chest syndrome (ACS) in patients with sickle cell disease (SCD) during a period where patients are well and during admission to the hospital for an acute sickle event to see if these measures can predict the development of ACS. Understanding events precipitating ACS may lead to preventative and interventional therapies which will improve patient outcomes and quality of life.